Millie
your market intelligence analyst
Search Results
1,187 results
Your search is now limited to «Immunotherapy» expert search.
News-Medical.net 10/21/2019 04:21
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma, a cancer that begins in certain immune system cells and can occur almost anywhere in the body.
More from News-Medical.net:
Channel NewsAsia (Singapore) 10/21/2019 01:35
World Roche's Tecentriq immunotherapy mixed with the older cancer drug Avastin lifted both overall survival and progression-free survival in people with liver cancer that cannot be surgically removed, the Swiss drugmaker said on Monday.
More from Channel NewsAsia (Singapore):
Business Wire 10/21/2019 01:00
About Genentech in personalized cancer immunotherapy For more than 30 years, Genentech has been developing medicines with the goal to redefine treatment in oncology.
More from Business Wire:
GlobeNewswire 10/21/2019 01:00
About Roche in cancer immunotherapy For more than 50 years, Roche has been developing medicines with the goal to redefine treatment in oncology.
More from GlobeNewswire:
ENDPOINTS 10/21/2019 00:33
The focus on myeloid cells as an avenue to broaden the therapeutic potential of immunotherapy is emerging quickly, and Verseau is positioned to make a significant impact on this field,” said Dr. George Golumbeski, Chairman of the Board of Verseau.
More from ENDPOINTS:
Xconomy 10/21/2019 00:18
Verseau Therapeutics aims to bring cancer immunotherapy to more people by targeting a type of immune cell present in the vast majority of tumors and directing it to fight the disease.
More from Xconomy:
Onclive 10/20/2019 06:00
Katrina S. Pedersen, MD, MS A new set of recommendations for the treatment of small bowel adenocarcinoma (SBA), a relatively rare type cancer of the gastrointestinal (GI) tract, have been created by the National Comprehensive Cancer Network (NCCN.
More from Onclive:
Immuno-Oncology News 10/18/2019 12:07
The study will begin to evaluate patients with ovarian cancer who failed one to two prior lines of treatment and colorectal cancer patients who received two to three prior therapies.
More from Immuno-Oncology News:
ClinicalTrials.gov 10/18/2019 07:36
Condition : Urothelial Cancer Intervention : Radiation: Stereotactic Ablative Radiation Sponsor : University of Texas Southwestern Medical Center Not yet recruiting.
More from ClinicalTrials.gov:
Johns Hopkins Medicine 10/18/2019 07:00
There are a lot of clinical trials that are available here,” she says of the Bloomberg~Kimmel Institute for Cancer Immunotherapy (BKI) at Johns Hopkins, a research powerhouse.
More from Johns Hopkins Medicine:
José Baselga, Executive Vice President, Oncology R&D, said: “Trastuzumab deruxtecan has the potential to transform the treatment landscape for patients with HER2-positive metastatic breast cancer who have limited treatment options today.
More from Pharmaceutical Business Review:
Technology Org 10/18/2019 02:30
The team analyzed samples of 318 patients from five different clinical trial data sets and not only confirmed the association between dissimilarity and promise as an immunotherapy target but also found that dissimilarity correlated to increased overall survival after PD-1 therapy in patients with non-small cell lung cancer.
More from Technology Org:
Non-small cell lung cancer can be treated by surgery, chemotherapy, radiation therapy, targeted therapies, and immunotherapy which is very costly.
More from Middle East North Africa Financial Network (MENAFN):
PR Newswire 10/17/2019 13:48
AIVITA is currently conducting three independent clinical studies investigating its platform immunotherapy in patients with ovarian cancer, glioblastoma and melanoma.
More from PR Newswire:
Targeted Oncology 10/17/2019 12:25
Corey J. Langer, MD In a Targeted Oncology case-based peer perspectives live discussion with a group of physicians, Corey J. Langer, MD, reviewed the potential for treatment with immunotherapy following chemoradiotherapy for patients with stage III non–small cell lung cancer (NSCLC.
More from Targeted Oncology:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications